In the past week, GPCR stock has gone up by 4.96%, with a monthly gain of 12.53% and a quarterly plunge of -6.64%. The volatility ratio for the week is 6.88%, and the volatility levels for the last 30 days are 6.57% for Structure Therapeutics Inc ADR . The simple moving average for the past 20 days is 5.25% for GPCR’s stock, with a -4.79% simple moving average for the past 200 days.
Is It Worth Investing in Structure Therapeutics Inc ADR (NASDAQ: GPCR) Right Now?
The 36-month beta value for GPCR is also noteworthy at -4.78. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for GPCR is 41.44M, and at present, short sellers hold a 7.82% of that float. The average trading volume of GPCR on April 10, 2024 was 579.50K shares.
GPCR) stock’s latest price update
Structure Therapeutics Inc ADR (NASDAQ: GPCR)’s stock price has gone decline by -6.60 in comparison to its previous close of 44.41, however, the company has experienced a 4.96% increase in its stock price over the last five trading days. InvestorPlace reported 2024-03-30 that With the major indexes at or near record highs, it’s been easy to overlook the performance of the small-cap Russell-2000 Index. While the index is “only” up about 5% in 2024, it’s up 21% in the past 12 months, and is slowly starting to catch up to the market rally.
Analysts’ Opinion of GPCR
JMP Securities, on the other hand, stated in their research note that they expect to see GPCR reach a price target of $90. The rating they have provided for GPCR stocks is “Mkt Outperform” according to the report published on October 19th, 2023.
Piper Sandler gave a rating of “Overweight” to GPCR, setting the target price at $58 in the report published on July 27th of the previous year.
GPCR Trading at -0.56% from the 50-Day Moving Average
After a stumble in the market that brought GPCR to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -44.71% of loss for the given period.
Volatility was left at 6.57%, however, over the last 30 days, the volatility rate increased by 6.88%, as shares surge +18.14% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -2.40% lower at present.
During the last 5 trading sessions, GPCR rose by +4.96%, which changed the moving average for the period of 200-days by +29.62% in comparison to the 20-day moving average, which settled at $39.73. In addition, Structure Therapeutics Inc ADR saw 1.77% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for GPCR
The total capital return value is set at -0.23. Equity return is now at value -33.29, with -30.87 for asset returns.
Based on Structure Therapeutics Inc ADR (GPCR), the company’s capital structure generated 0.01 points at debt to capital in total, while cash flow to debt ratio is standing at -14.61. The debt to equity ratio resting at 0.01. The interest coverage ratio of the stock is -27.0.
Currently, EBITDA for the company is -101.74 million with net debt to EBITDA at 1.21. The liquidity ratio also appears to be rather interesting for investors as it stands at 19.14.
Conclusion
In summary, Structure Therapeutics Inc ADR (GPCR) has had a better performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
